Clarus 700 receives FDA clearance

The FDA has issued 510(k) clearance to Zeiss’s Clarus 700 ultra-widefield imaging system, the company announced in a press release.

Clarus 700, a high-resolution system with true color and a full range of fundus imaging modalities, allows physicians to capture small details from the macula to the periphery, the release said.

“Zeiss has been at the forefront of industry-defining advancements that have made Clarus the industry’s standard of care for identifying retinal and glaucoma disease,” Jim Mazzo, Zeiss global president of ophthalmic devices, said in the release. “From early detection to postoperative evaluation, we’re here to support our customers, every step of the way.”

The FDA has issued 510(k) clearance to Zeiss’s Clarus 700 ultra-widefield imaging system, the company announced in a press release.

Clarus 700, a high-resolution system with true color and a full range of fundus imaging modalities, allows physicians to capture small details from the macula to the periphery, the release said.

“Zeiss has been at the forefront of industry-defining advancements that have made Clarus the industry’s standard of care for identifying retinal and glaucoma disease,” Jim Mazzo, Zeiss global president of ophthalmic devices, said in the release. “From early detection to postoperative evaluation, we’re here to support our customers, every step of the way.”